Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

American Journal of Ophthalmology

Volumn 129, Issue 6, 2000, Pages 723-727

  Stewart, William C ^a,b   Sharpe, Elizabeth D ^c   Harbin Jr , Thomas S ^d   Pastor, Scott A ^d   Day, Douglas G ^e   Holmes, Keri T ^a   Stewart, Jeanette A ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Ophthalmology Consultants   (United States)

^d Eye Consultants of Atlanta   (United States)

^e Omni Eye Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; DORZOLAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EYE IRRITATION; FATIGUE; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LIFESTYLE; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PAIN; PRIMARY GLAUCOMA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADRENERGIC ALPHA-AGONISTS; CARBONIC ANHYDRASE INHIBITORS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUINOXALINES; SAFETY; SULFONAMIDES; THIOPHENES; TREATMENT OUTCOME;

EID: 0033859558     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00381-0     Document Type: Article

References (17)

1. Book SA. Essentials of statistics. New York: McGraw Hill Book Company, 1978:117-122,205-215.
2. Duff G.R. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intraocular pressure. Acta Ophhtalmologica. 65:1987;618-621.
3. Stewart W.C., Leland T.M., Cate E.A., Stewart J.A. Efficacy and safety of timolol solution once daily vs. timolol gel in treating elevated IOP. J Glaucoma. 7:1998;402-407.
4. Rosner B. Fundamentals of biostatistics. 1982;336-341 Duxbury Press, Boston.
5. Siegel S. Nonparametric statistics. Series in psychology. 1956;63-67 McGraw Hill, New York.
6. Lippa E.A., Carlson L.E., Ehinger B., et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol. 110:1992;495-499.
7. Lippa E.A., Schuman J.S., Higginbotham E.J., et al. MK-507 versus sezolamide comparative efficacy of two topically active carbonic anhydrase inhibitors . Ophthalmology. 98:1991;308-313.
8. Wilkerson M., Cyrlin M., Lippa E.A., et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol. 111:1993;1343-1350.
9. Kitazawa Y., Azuma I., Iwata K., et al. Dorzolamide, a topical carbonic anhydrase inhibitor a two-week dose response study in patients with glaucoma or ocular hypertension . J Glaucoma. 3:1994;275-279.
10. Strahlman E., Tipping R., Vogel R. A double masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol. 113:1995;1009-1016.
11. Laibovitz R., Strahlman E.R., Barber B.L., Strohmaier K.M. Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucoma. J Glaucoma. 4:1995;306-313.
12. Walters TR. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies. Surv Ophthalmol 1996;(suppl 1):S19-S26.
13. Derick R.J., Walters T.R., Robin A.L., et al. Brimonidine tartrate a one month dose response study . Invest Ophthalmol Vis Sci. 34:(suppl):1993;1138.
14. Nordland J.R., Pasquale L.R., Robin A.L., et al. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol. 113:1995;77-83.
15. Boyle J.E., Ghosh K., Gieser D.K., Adamsons I.A. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group. Ophthalmology. 105:1998;1945-1951.
16. Gilman A.G., Goodman L.S., Rall T.W., Murad F. The pharmacological basis of therapeutics. 1985;33 Macmillan Publishing, New York.
17. Reid J.L. Alpha-adrenergic receptors and blood pressure control. Am J Cardiol. 57:1986;6E-12E.